TipRanks
Go Ultimate55% OFF

ilShinbiobase Co., Ltd. (068330) AI Stock Analysis

KR:068330

ilShinbiobase Co., Ltd.

(Korea Exchange:068330)

Select Model
Rating:73Outperform
Price Target:KRW 1,115.00â–²(10.51% Upside)
Action:initiatedcoverage
Date:10/28/26

The score is driven primarily by strong financial performance—high margins and a very low-risk, near-debt-free balance sheet—partly offset by cash-flow variability and uneven revenue history. Technical indicators are currently weak (negative MACD and price below key moving averages), while valuation is supportive with a reasonable P/E and a modest dividend yield.

Positive Factors
High and sustained profitabilityPersistently high gross and net margins indicate strong profitability across the reported period, while the 2025 EBIT margin remained robust. This gives the company room to absorb operating variability, reinvest in its business, and preserve earnings power over the coming quarters.
Negative Factors
Uneven revenue trajectoryThe history of multiple revenue declines shows that top-line performance has not followed a consistently compounding path. Although 2025 rebounded strongly, the uneven pattern suggests exposure to cyclical demand or contract timing, making future growth less predictable.

ilShinbiobase Co., Ltd. (068330) vs. SPDR S&P 500 ETF (SPY)

-50%-40%-30%-20%-10%0%10%20%30%KR:068330-32.21%SPY+11.79%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
KRW 42.05B
Dividend Yield
0.93%
Average Volume (3M)
93.81K
Price to Earnings (P/E)
10.2
Beta (1Y)
0.21
Revenue Growth
32.31%
EPS Growth
66.46%
Country
KR
Employees
―
Sector
General
Sector Strength
55
Industry
Industrial - Machinery

ilShinbiobase Co., Ltd. Business Overview & Revenue Model

Company Description

Operating out of South Korea, ilShinbiobase Co Ltd specializes in producing industrial-grade equipment for both refrigeration and freezing purposes.

ilShinbiobase Co., Ltd. Financial Statement Overview

Summary

Strong overall fundamentals led by an exceptionally conservative balance sheet (near-zero leverage) and high profitability (strong gross and net margins). Offsetting factors are uneven revenue trends (multiple down years before a 2025 rebound) and recent free-cash-flow weakness/volatility, which suggests results can be cyclical and cash generation can fluctuate.

Income Statement

78Positive

Balance Sheet

92Very Positive

Cash Flow

74Positive
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue15.16B14.53B10.82B16.44B20.43B24.38B
Gross Profit7.85B7.59B6.28B9.43B10.51B12.66B
EBITDA4.96B4.98B2.70B8.22B5.17B8.39B
Net Income5.11B4.79B3.81B6.23B3.82B5.86B
Balance Sheet
Total Assets72.69B68.58B63.94B60.62B58.45B56.44B
Cash, Cash Equivalents and Short-Term Investments47.41B42.67B37.24B33.49B27.71B25.58B
Total Debt0000768.46K9.87M
Total Liabilities7.33B3.79B3.49B3.55B4.63B6.36B
Stockholders Equity65.35B64.80B60.45B57.06B53.82B50.08B
Cash Flow
Free Cash Flow8.66B5.26B4.07B5.66B2.12B5.97B
Operating Cash Flow8.65B5.27B4.12B5.92B2.65B6.74B
Investing Cash Flow-7.98B-4.73B-5.26B-5.81B-7.98B-4.11B
Financing Cash Flow0-291.74M-291.74M-2.65B-309.30M-308.53M

ilShinbiobase Co., Ltd. Technical Analysis

Technical Analysis SentimentNeutral
Last Price1009.00

Price Trends

50DMA1038.08Negative
100DMA1014.33Negative
200DMA1249.86Negative

Market Momentum

MACD-9.73Negative
RSI49.70Neutral
STOCH74.79Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For KR:068330, the sentiment is Neutral. The current price of 1009.00 is above the 20-day moving average (MA) of 1002.30, below the 50-day MA of 1038.08, and below the 200-day MA of 1249.86, indicating a neutral trend. The MACD of -9.73 indicates Negative momentum. The RSI at 49.70 is Neutral, neither overbought nor oversold. The STOCH value of 74.79 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for KR:068330.

ilShinbiobase Co., Ltd. Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

KR:068330 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
KR:068330KR:06833073OutperformKRW 42.05B10.24―0.93%32.31%66.46%
KR:484870KR:48487071OutperformKRW 365.24B8.52―18.73%18.42%13.92%
KR:000850KR:00085061NeutralKRW 75.46B3.69―3.79%11.17%198.24%
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%
KR:004380KR:00438045NeutralKRW 147.29B-9.76―0.69%-3.31%53.68%
KR:011700KR:01170043NeutralKRW 64.05B-253.85―1.01%-18.23%91.72%
KR:007460KR:00746041NeutralKRW 9.15B-0.06――9.08%-32.52%

* General Sector Average

Performance Comparison

-50%0%50%KR:068330KR:000850KR:004380KR:007460KR:011700KR:484870Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
KR:068330 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
KR:068330ilShinbiobase Co., Ltd.1009.00-442.73-30.50%
KR:000850Hwacheon Machine Tool Co., Ltd34300.004225.9414.05%
KR:004380Samik THK Co., Ltd.7220.00-2640.00-26.77%
KR:007460Aprogen, Inc1870.00-7205.00-79.39%
KR:011700Hanshin Machinery Co., Ltd1980.00-1452.19-42.31%
KR:484870MNC Solution Co., Ltd.13300.00-49328.50-78.76%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 28, 2026